Kodiak Sciences Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of innovative treatments for prevalent retinal diseases. The company leverages its proprietary Antibody Biopolymer Conjugate (AB…
HQ: Palo Alto, CA, United States of Americakodiak.com
USD111.19+2.72%vs prev. close
Performance
1W
+11.97%
1M
+37.12%
3M
+168.90%
1Y
+489.24%
YTD
+297.68%
Valuation
P/E
—
EPS TTM
-4.19
Dividend yield
—
Size and risk
Market cap
$7.0B
Beta
—
Price history
KOD price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Kodiak Sciences
KOD
Biotechnology
Mkt cap (USD bn)
7.0
P/E
—
Div yld
—
1W
+12.0%
1M
+37.1%
3M
+168.9%
6M
+200.3%
1Y
+489.2%
YTD
+297.7%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Kodiak Sciences
KOD
Biotechnology
7.0
—
—
+12.0%
+37.1%
+168.9%
+200.3%
+489.2%
+297.7%
Subscribe to Equity Analytics to compare KOD with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.